{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:35:40Z","timestamp":1789846540769,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 degli Studi di Catania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02513-7","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:33:34Z","timestamp":1777138414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of New P2X7R Antagonists on Retinal Inflammatory Degenerative Conditions"],"prefix":"10.1007","volume":"49","author":[{"given":"Chiara Bianca Maria","family":"Platania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Consiglia","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Panico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lazzara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Claudia","family":"Lepre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Settimio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bucolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"2513_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.114942","volume":"198","author":"Chiara Bianca Platania","year":"2022","unstructured":"Platania, Chiara Bianca, Filippo Maria Drago, and Claudio Bucolo. 2022. The P2X7 receptor as a new pharmacological target for retinal diseases. Biochemical Pharmacology 198: 114942. https:\/\/doi.org\/10.1016\/j.bcp.2022.114942.","journal-title":"Biochemical Pharmacology"},{"key":"2513_CR2","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1111\/febs.17075","volume":"291","author":"Huiling Hu","year":"2024","unstructured":"Hu, Huiling, Danyao Nie, Min Fang, Wenling He, Jing Zhang, Xinhua Liu, and Guoming Zhang. 2024. M\u00fcller cells under hydrostatic pressure modulate retinal cell survival via TRPV1\/PLC\u03b31 complex-mediated calcium influx in experimental glaucoma. FEBS Journal 291: 2703\u20132714. https:\/\/doi.org\/10.1111\/febs.17075.","journal-title":"FEBS Journal"},{"key":"2513_CR3","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s00125-022-05775-6","volume":"65","author":"Jose-Andres C. Portillo","year":"2022","unstructured":"Portillo, Jose-Andres C.., Jin-Sang. Yu, Sarah Vos, Reena Bapputty, Yalitza Lopez Corcino, Alyssa Hubal, Jad Daw, et al. 2022. Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in M\u00fcller cells. Diabetologia 65: 2157\u20132171. https:\/\/doi.org\/10.1007\/s00125-022-05775-6.","journal-title":"Diabetologia"},{"key":"2513_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11302-022-09894-y","volume":"18","author":"Candace Drysdale","year":"2022","unstructured":"Drysdale, Candace, Keunha Park, Kirstan A. Vessey, Emily Xin Huang, Yihan Caruso, Joelyn Li, and Wong et al. 2022. P2X7-mediated alteration of membrane fluidity is associated with the late stages of age-related macular degeneration. Purinergic Signalling 18:469\u2013479. https:\/\/doi.org\/10.1007\/s11302-022-09894-y","journal-title":"Purinergic Signalling"},{"key":"2513_CR5","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Gil, Natalia, Oksana Kutsyr, Agustina Noailles, and Laura Fern\u00e1ndez-S\u00e1nchez et al. 2022. Lorena Vidal, Xavier S\u00e1nchez-S\u00e1ez, Carla S\u00e1nchez-Castillo,. Purinergic Receptors P2X7 and P2X4 as Markers of Disease Progression in the rd10 Mouse Model of Inherited Retinal Dystrophy. International Journal of Molecular Sciences 23: 14758. https:\/\/doi.org\/10.3390\/ijms232314758","DOI":"10.3390\/ijms232314758"},{"key":"2513_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bcp.2017.05.001","volume":"138","author":"Chiara Bianca Platania","year":"2017","unstructured":"Platania, Chiara Bianca, Giovanni Maria, Luisa Di Giurdanella, Gian Marco Paola, Filippo Leggio, Salvatore Drago, Salomone, and Claudio Bucolo. 2017. P2X7 receptor antagonism: Implications in diabetic retinopathy. Biochemical Pharmacology 138:130\u2013139. https:\/\/doi.org\/10.1016\/j.bcp.2017.05.001","journal-title":"Biochemical Pharmacology"},{"key":"2513_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2016.206","volume":"36","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio, F., and E. Adinolfi. 2017. Extracellular purines, purinergic receptors and tumor growth. Oncogene 36: 293\u2013303. https:\/\/doi.org\/10.1038\/onc.2016.206.","journal-title":"Oncogene"},{"key":"2513_CR8","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1007\/s00210-024-02994-z","volume":"397","author":"Simran Soni","year":"2024","unstructured":"Soni, Simran, Mihir S.. Lukhey, Baban S.. Thawkar, Meena Chintamaneni, Ginpreet Kaur, Hemant Joshi, Seema Ramniwas, and Hardeep Singh Tuli. 2024. A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: A patent review on antagonists. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology 397: 4643\u20134656. https:\/\/doi.org\/10.1007\/s00210-024-02994-z.","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"2513_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.2174\/0929867330666230403094538","volume":"31","author":"El Idrissi","year":"2024","unstructured":"Idrissi, El., Imane Ghafir, Sabina Podlewska, Carmen Abate, Andrzej J.. Bojarski, Enza Lacivita, and Marcello Leopoldo. 2024. Structure-activity relationships and therapeutic potential of purinergic P2X7 receptor antagonists. Current Medicinal Chemistry 31: 1361\u20131403. https:\/\/doi.org\/10.2174\/0929867330666230403094538.","journal-title":"Current Medicinal Chemistry"},{"key":"2513_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106796","volume":"140","author":"Qasim Shah","year":"2023","unstructured":"Shah, Qasim, Zahid Hussain, Bilal Ahmad Khan, Kenneth A.. Jacobson, and Jamshed Iqbal. 2023. Synthesis and biological evaluation of carboxamide and quinoline derivatives as P2X7R antagonists. Bioorganic Chemistry 140: 106796. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106796.","journal-title":"Bioorganic Chemistry"},{"key":"2513_CR11","doi-asserted-by":"publisher","first-page":"175999","DOI":"10.1016\/j.ejphar.2023.175999","volume":"957","author":"Jo\u00e3o Carlos Mafra","year":"2023","unstructured":"Mafra, Jo\u00e3o Carlos, Nubia Martins, Guilherme Pegas Boechat, Teixeira, and Faria Robson Xavier. 2023. Synthetic molecules as P2X7 receptor antagonists: A medicinal chemistry update focusing the therapy of inflammatory diseases. European Journal of Pharmacology 957:175999. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175999","journal-title":"European Journal of Pharmacology"},{"key":"2513_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"Diego Dal Di Virgilio, Francesco","year":"2017","unstructured":"Di Virgilio, Francesco, Diego Dal, Alba Clara Ben, Anna Lisa Sarti, Giuliani, and Simonetta Falzoni. 2017. The P2X7 Receptor in Infection and Inflammation. Immunity 47:15\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.020","journal-title":"Immunity"},{"key":"2513_CR13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.22153","volume":"5","author":"Akira Karasawa","year":"2016","unstructured":"Karasawa, Akira, and Toshimitsu Kawate. 2016. Structural basis for subtype-specific inhibition of the P2X7 receptor. eLife 5: e22153. https:\/\/doi.org\/10.7554\/eLife.22153.","journal-title":"eLife"},{"key":"2513_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2019.09.017","volume":"179","author":"Alanna E. McCarthy","year":"2019","unstructured":"McCarthy, Alanna E.., Craig Yoshioka, and Steven E.. Mansoor. 2019. Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization. Cell 179: 659-670e13. https:\/\/doi.org\/10.1016\/j.cell.2019.09.017.","journal-title":"Cell"},{"key":"2513_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0530-4","volume":"6","author":"Rasha Al-Khalidi","year":"2018","unstructured":"Al-Khalidi, Rasha, Chiara Panicucci, Paul Cox, Natalia Chira, Justyna R\u00f3g, Christopher N. J.. Young, Rhiannon E.. McGeehan, et al. 2018. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism. Acta Neuropathologica Communications 6: 27. https:\/\/doi.org\/10.1186\/s40478-018-0530-4.","journal-title":"Acta Neuropathologica Communications"},{"key":"2513_CR16","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1111\/bph.14787","volume":"176","author":"Sarah Rosli","year":"2019","unstructured":"Rosli, Sarah, Francis J.. Kirby, Kate E.. Lawlor, Kate Rainczuk, Grant R.. Drummond, Ashley Mansell, and Michelle D.. Tate. 2019. Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection. British Journal of Pharmacology 176: 3834\u20133844. https:\/\/doi.org\/10.1111\/bph.14787.","journal-title":"British Journal of Pharmacology"},{"key":"2513_CR17","doi-asserted-by":"publisher","unstructured":"Fresta, Claudia, Giuseppe Giuseppina, Annamaria Caruso, and Fidilio. Chiara Bianca Maria Platania, Nicol\u00f2 Musso, Filippo Caraci, Filippo Drago, and Claudio Bucolo. 2020. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor. International Journal of Molecular Sciences 21: 9305. https:\/\/doi.org\/10.3390\/ijms21239305","DOI":"10.3390\/ijms21239305"},{"key":"2513_CR18","unstructured":"Raina, Parth M., and Preeti Patel, Mayur Parmar. 2025. Bazedoxifene. In StatPearls, Treasure Island (FL): StatPearls Publishing."},{"key":"2513_CR19","doi-asserted-by":"publisher","first-page":"106548","DOI":"10.1016\/j.bioorg.2023.106548","volume":"136","author":"Hadeer K Swedan","year":"2023","unstructured":"Swedan, Hadeer K., E. Asmaa, Ehab M. Kassab, Gedawy, and Salwa E. Elmeligie. 2023. Topoisomerase II inhibitors design: Early studies and new perspectives. Bioorganic Chemistry 136:106548. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106548","journal-title":"Bioorganic Chemistry"},{"key":"2513_CR20","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2165\/00003495-200868100-00006","volume":"68","author":"Jennifer S Orman","year":"2008","unstructured":"Orman, Jennifer S., and MPerry Caroline. 2008. Tipranavir: A review of its use in the management of HIV infection. Drugs 68: 1435\u20131463. https:\/\/doi.org\/10.2165\/00003495-200868100-00006.","journal-title":"Drugs"},{"key":"2513_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/glia.20904","volume":"58","author":"M Cerciat","year":"2010","unstructured":"Cerciat, M., M. Unkila, L.M. Garcia-Segura, and M.-A. Arevalo. 2010. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 58: 93\u2013102. https:\/\/doi.org\/10.1002\/glia.20904.","journal-title":"Glia"},{"key":"2513_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12751","volume":"31","author":"Mar\u00eda C. Burguete","year":"2019","unstructured":"Burguete, Mar\u00eda C.., Teresa Jover-Mengual, Mikahela A.. L\u00f3pez-Morales, Alicia Aliena-Valero, Mar\u00eda Jorques, Germ\u00e1n Torregrosa, Enrique Alborch, Mar\u00eda Castell\u00f3-Ruiz, and Juan B.. Salom. 2019. The selective oestrogen receptor modulator, bazedoxifene, mimics the neuroprotective effect of 17\u03b2-oestradiol in diabetic ischaemic stroke by modulating oestrogen receptor expression and the MAPK\/ERK1\/2 signalling pathway. Journal of Neuroendocrinology 31: e12751. https:\/\/doi.org\/10.1111\/jne.12751.","journal-title":"Journal of Neuroendocrinology"},{"key":"2513_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10787-017-0388-2","volume":"26","author":"Jingjia Yan","year":"2018","unstructured":"Yan, Jingjia, Jiaxiao Sun, and Zhiyuan Zeng. 2018. Teniposide ameliorates bone cancer nociception in rats via the P2X7 receptor. Inflammopharmacology 26: 395\u2013402. https:\/\/doi.org\/10.1007\/s10787-017-0388-2.","journal-title":"Inflammopharmacology"},{"key":"2513_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108264","volume":"101","author":"Jiaxin Zhang","year":"2021","unstructured":"Zhang, Jiaxin, Haoxin Zhao, Yuan Feng, Xin Xu, Yili Yang, Pengxia Zhang, Zhiliang Lu, and Tao Zhang. 2021. Topoisomerase 2 inhibitor etoposide promotes interleukin-10 production in LPS-induced macrophages via upregulating transcription factor Maf and activating PI3K\/Akt pathway. International Immunopharmacology 101: 108264. https:\/\/doi.org\/10.1016\/j.intimp.2021.108264.","journal-title":"International Immunopharmacology"},{"key":"2513_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MPH.0b013e31814fb7ea","volume":"29","author":"C\u00e9lia Beatriz Antoneli","year":"2007","unstructured":"Antoneli, C\u00e9lia Beatriz, Karina B. Gianotti, Carlos Rodriguez-Galindo Ribeiro, Fernando A. Soares, A. Victor, E. R. S. Arias, Paulo, Martha M. Novaes, Chojniak, and M\u00e1rcio Malogolowkin. 2007. The addition of ifosfamide\/etoposide to cisplatin\/teniposide improves the survival of children with retinoblastoma and orbital involvement. Journal of Pediatric Hematology\/Oncology 29:700\u2013704. https:\/\/doi.org\/10.1097\/MPH.0b013e31814fb7ea","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"2513_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.oret.2020.02.015","volume":"4","author":"Junyang Zhao","year":"2020","unstructured":"Zhao, Junyang, Zhao Xun Feng, Meirong Wei, Guohua Liu, Carlos E.. Solarte, Bin Li, Yizhuo Wang, Chengyue Zhang, and Brenda L.. Gallie. 2020. Impact of systemic chemotherapy and delayed enucleation on survival of children with advanced intraocular retinoblastoma. Ophthalmology Retina 4: 630\u2013639. https:\/\/doi.org\/10.1016\/j.oret.2020.02.015.","journal-title":"Ophthalmology Retina"},{"key":"2513_CR27","first-page":"4357","volume":"25","author":"Laurence Maggiorella","year":"2005","unstructured":"Maggiorella, Laurence, Bixiu Wen, Valerie Frascogna, Paule Opolon, Jean Bourhis, and Eric Deutsch. 2005. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model. Anticancer Research 25: 4357\u20134362.","journal-title":"Anticancer Research"},{"key":"2513_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1593\/neo.06535","volume":"8","author":"Nabendu Pore","year":"2006","unstructured":"Pore, Nabendu, Anjali K.. Gupta, George J.. Cerniglia, and Amit Maity. 2006. HIV protease inhibitors decrease VEGF\/HIF-1\u03b1 expression and angiogenesis in glioblastoma cells. Neoplasia 8: 889\u2013895. https:\/\/doi.org\/10.1593\/neo.06535.","journal-title":"Neoplasia"},{"key":"2513_CR29","first-page":"864","volume":"43","author":"G Limb","year":"2002","unstructured":"Limb, G., Thomas E. Astrid, M. G. Salt, Peter, Stephen E. Munro, Moss, and Peng T. Khaw. 2002. In vitro characterization of a spontaneously immortalized human M\u00fcller cell line (MIO-M1). Investigative Ophthalmology & Visual Science 43:864\u2013869.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"2513_CR30","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Albarral, Jose A., I. Ana, Jos\u00e9 A. Ram\u00edrez, Rosa de Hoz, Juan J. Matamoros, and Salazar. 2024. and Jos\u00e9 M. Ram\u00edrez. Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage. Frontiers in Cellular Neuroscience 18: 1354569. https:\/\/doi.org\/10.3389\/fncel.2024.1354569","DOI":"10.3389\/fncel.2024.1354569"},{"key":"2513_CR31","doi-asserted-by":"publisher","unstructured":"Lazzara, Francesca, Anna Maria Longo, Giovanni Giurdanella, and Gabriella Lupo. Chiara Bianca Maria Platania, Settimio Rossi, Filippo Drago, Carmelina Daniela Anfuso, and Claudio Bucolo. 2022. Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy. Frontiers in Pharmacology 13: 971164. https:\/\/doi.org\/10.3389\/fphar.2022.971164","DOI":"10.3389\/fphar.2022.971164"},{"key":"2513_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.phrs.2007.04.016","volume":"55","author":"Net Das Evcimen","year":"2007","unstructured":"Das Evcimen, Net, and George L.. King. 2007. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacological Research 55: 498\u2013510. https:\/\/doi.org\/10.1016\/j.phrs.2007.04.016.","journal-title":"Pharmacological Research"},{"key":"2513_CR33","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","volume":"149","author":"Valeria Tarallo","year":"2012","unstructured":"Tarallo, Valeria, Yoshio Hirano, Bradley D.. Gelfand, Sami Dridi, Nagaraj Kerur, Younghee Kim, Won Gil Cho, et al. 2012. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149: 847\u2013859. https:\/\/doi.org\/10.1016\/j.cell.2012.03.036.","journal-title":"Cell"},{"key":"2513_CR34","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1167\/iovs.13-12500","volume":"54","author":"Nagaraj Kerur","year":"2013","unstructured":"Kerur, Nagaraj, Yoshio Hirano, Valeria Tarallo, Benjamin J.. Fowler, Ana Bastos-Carvalho, Tetsuhiro Yasuma, Reo Yasuma, et al. 2013. TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy. Investigative Ophthalmology & Visual Science 54: 7395\u20137401. https:\/\/doi.org\/10.1167\/iovs.13-12500.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"2513_CR35","doi-asserted-by":"publisher","first-page":"113908","DOI":"10.1016\/j.bcp.2020.113908","volume":"175","author":"Chiara Bianca Platania","year":"2020","unstructured":"Platania, Chiara Bianca, Valeria Maria, Alessia Pittal\u00e0, Nicoletta Pascale, Carmelina Daniela Marchesi, Gabriella Anfuso, Martina Lupo, and Cristaldi et al. 2020. Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells. Biochemical Pharmacology 175:113908. https:\/\/doi.org\/10.1016\/j.bcp.2020.113908","journal-title":"Biochemical Pharmacology"},{"key":"2513_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207528","volume":"21","author":"Giovanni Giurdanella","year":"2020","unstructured":"Giurdanella, Giovanni, Gabriella Lupo, Florinda Gennuso, Federica Conti, Debora Lo Furno, Giuliana Mannino, Carmelina Daniela Anfuso, Filippo Drago, Salvatore Salomone, and Claudio Bucolo. 2020. Activation of the VEGF-A\/ERK\/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy. International Journal of Molecular Sciences 21: 7528. https:\/\/doi.org\/10.3390\/ijms21207528.","journal-title":"International Journal of Molecular Sciences"},{"key":"2513_CR37","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2711308","volume":"27","author":"Carmelina Anfuso","year":"2022","unstructured":"Anfuso, Carmelina, Giovanni Daniela, Anna Giurdanella, Alessia Longo, Aleksandra Cosentino, Dario Agafonova, and Gabriella Lupo Rusciano. 2022. Antioxidant activity of cyanidin-3-O-glucoside and verbascoside in an in vitro model of diabetic retinopathy. Frontiers in Bioscience-Landmark 27: 308. https:\/\/doi.org\/10.31083\/j.fbl2711308.","journal-title":"Frontiers in Bioscience-Landmark"},{"key":"2513_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1006\/jmbi.1997.1161","volume":"271","author":"TH Shaikh","year":"1997","unstructured":"Shaikh, T.H., A.M. Roy, J. Kim, M.A. Batzer, and P.L. Deininger. 1997. cDNAs derived from primary and small cytoplasmic Alu (scAlu) transcripts. Journal of Molecular Biology 271: 222\u2013234. https:\/\/doi.org\/10.1006\/jmbi.1997.1161.","journal-title":"Journal of Molecular Biology"},{"key":"2513_CR39","doi-asserted-by":"publisher","unstructured":"Marchesi, Nicoletta, Pasquale Linciano, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, and Daniela Rossi. Giosu\u00e8 Costa, Francesca Alessandra Ambrosio, Annalisa Barbieri, Simona Collina, and Alessia Pascale. 2023. Short- and Long-Term Regulation of HuD: A Molecular Switch Mediated by Folic Acid? International Journal of Molecular Sciences 24: 12201. https:\/\/doi.org\/10.3390\/ijms241512201","DOI":"10.3390\/ijms241512201"},{"key":"2513_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"Stephen A. Bustin","year":"2009","unstructured":"Bustin, Stephen A.., Vladimir Benes, Jeremy A.. Garson, Jan Hellemans, Jim Huggett, Mikael Kubista, Reinhold Mueller, et al. 2009. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 55: 611\u2013622. https:\/\/doi.org\/10.1373\/clinchem.2008.112797.","journal-title":"Clinical Chemistry"},{"key":"2513_CR41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1124\/mol.117.111021","volume":"93","author":"Rebecca C. Allsopp","year":"2018","unstructured":"Allsopp, Rebecca C.., Sudad Dayl, Anfal Bin Dayel, Ralf Schmid, and Richard J.. Evans. 2018. Mapping the allosteric action of antagonists A740003 and A438079 reveals a role for the left flipper in ligand sensitivity at P2X7 receptors. Molecular Pharmacology 93: 553\u2013562. https:\/\/doi.org\/10.1124\/mol.117.111021.","journal-title":"Molecular Pharmacology"},{"key":"2513_CR42","doi-asserted-by":"publisher","unstructured":"Srivastava, Girish K., L. Maria, Ivan Alonso-Alonso, T. Fernandez-Bueno, Maria, Fernando Garcia-Gutierrez, Rosa M. Rull, Coco, and J. Carlos. 2018. Pastor. Comparison between direct contact and extract exposure methods for PFO cytotoxicity evaluation. Scientific Reports 8: 1425. https:\/\/doi.org\/10.1038\/s41598-018-19428-5","DOI":"10.1038\/s41598-018-19428-5"},{"key":"2513_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.951833","volume":"13","author":"F Fahmideh","year":"2022","unstructured":"Fahmideh, F., N. Marchesi, L.I.M. Campagnoli, L. Landini, C. Caramella, A. Barbieri, S. Govoni, and A. Pascale. 2022. Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: A new option to target early stages of diabetic retinopathy? Frontiers in Pharmacology 13: 951833. https:\/\/doi.org\/10.3389\/fphar.2022.951833.","journal-title":"Frontiers in Pharmacology"},{"key":"2513_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00414","volume":"14","author":"Elif Do\u01e7an","year":"2020","unstructured":"Do\u01e7an, Elif, Hatice Ayg\u00fcn, G\u00f6khan. Arslan, Emil Rzayev, Bahattin Avc\u0131, Mustafa Ayy\u0131ld\u0131z, and Erdal A\u011far. 2020. The role of NMDA receptors in the effect of purinergic P2X7 receptor on spontaneous seizure activity in WAG\/Rij rats with genetic absence epilepsy. Frontiers in Neuroscience 14: 414. https:\/\/doi.org\/10.3389\/fnins.2020.00414.","journal-title":"Frontiers in Neuroscience"},{"key":"2513_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.neuroscience.2016.10.005","volume":"339","author":"Ryan L O\u2019Hare Doig","year":"2016","unstructured":"O\u2019Hare Doig, Ryan L., A. Carole, Nicole M. Bartlett, I. Smith, Stuart, Sarah A. Hodgetts, Livia Dunlop, Hool, and Melinda Fitzgerald. 2016. Specific combinations of ion channel inhibitors reduce excessive Ca2\u2009+\u2009influx as a consequence of oxidative stress and increase neuronal and glial cell viability in vitro. Neuroscience 339:450\u2013462. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.10.005","journal-title":"Neuroscience"},{"key":"2513_CR46","doi-asserted-by":"publisher","unstructured":"Campagno, Keith E., Wennan Lu, Assraa Hassan Jassim, Farraj Albalawi, Aurora Cenaj, Huen-Yee Tso, P. Sophia, Clark, Puttipong Sripinun, N\u00e9stor M\u00e1s G\u00f3mez, and Claire H. Mitchell. 2021. Rapid morphologic changes to microglial cells and upregulation of mixed microglial activation state markers induced by P2X7 receptor stimulation and increased intraocular pressure. Journal of Neuroinflammation 18: 217. https:\/\/doi.org\/10.1186\/s12974-021-02251-7","DOI":"10.1186\/s12974-021-02251-7"},{"key":"2513_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00227","volume":"11","author":"Farraj Albalawi","year":"2017","unstructured":"Albalawi, Farraj, Wennan Lu, Jonathan M.. Beckel, Jason C.. Lim, A. Stuart. McCaughey, and Claire H.. Mitchell. 2017. The P2X7 receptor primes IL-1\u03b2 and the NLRP3 inflammasome in astrocytes exposed to mechanical strain. Frontiers in Cellular Neuroscience 11: 227. https:\/\/doi.org\/10.3389\/fncel.2017.00227.","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"2513_CR48","doi-asserted-by":"publisher","first-page":"114199","DOI":"10.1016\/j.bcp.2020.114199","volume":"180","author":"Giovanni Romano","year":"2020","unstructured":"Romano, Giovanni, Rosario Luca, Francesca Amato, Vittorio Lazzara, Tsung-Han Porciatti, Filippo Chou, Drago, and Claudio Bucolo. 2020. P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice. Biochemical Pharmacology 180:114199. https:\/\/doi.org\/10.1016\/j.bcp.2020.114199","journal-title":"Biochemical Pharmacology"},{"key":"2513_CR49","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/cbin.12030","volume":"47","author":"Huiling Hu","year":"2023","unstructured":"Hu, Huiling, Xinhua Liu, Danyao Nie, Min Fang, Jing Zhang, and Guoming Zhang. 2023. Insights into CD154-mediated pathways in ocular hypertensive glaucoma: The role of M\u00fcller cells and P2X7 in retinal neuroprotection and therapeutic potential. Cell Biology International 47: 1441\u20131452. https:\/\/doi.org\/10.1002\/cbin.12030.","journal-title":"Cell Biology International"},{"key":"2513_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bcp.2019.07.010","volume":"168","author":"Chiara Bianca Platania","year":"2019","unstructured":"Platania, Chiara Bianca, Francesca Maria, Annamaria Lazzara, Claudia Giuseppina Fidilio, Federica Fresta, Giovanni Conti, Gian Marco Giurdanella, Salvatore Leggio, Filippo Salomone, Drago, and Claudio Bucolo. 2019. Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor. Biochemical Pharmacology 168:249\u2013258. https:\/\/doi.org\/10.1016\/j.bcp.2019.07.010","journal-title":"Biochemical Pharmacology"},{"key":"2513_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04786-w","volume":"13","author":"Hui Kong","year":"2022","unstructured":"Kong, Hui, Hongran Zhao, Tianran Chen, Yanling Song, and Yan Cui. 2022. Targeted P2X7\/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy. Cell Death & Disease 13: 336.","journal-title":"Cell Death & Disease"},{"key":"2513_CR52","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00592-019-01343-4","volume":"56","author":"Carmen Clapp","year":"2019","unstructured":"Clapp, Carmen, Nundehui Diaz-Lezama, Elva Adan-Castro, Gabriela Ramirez-Hernandez, Bibiana Moreno-Carranza, Alba Clara Sarti, Simonetta Falzoni, Anna Solini, and Francesco Di Virgilio. 2019. Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes. Acta Diabetologica 56: 1031\u20131036. https:\/\/doi.org\/10.1007\/s00592-019-01343-4.","journal-title":"Acta Diabetologica"},{"key":"2513_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrc.2016.10.140","volume":"482","author":"Kyle A. Carver","year":"2017","unstructured":"Carver, Kyle A.., C.M. Lin, Catherine Bowes Rickman, and Dongli Yang. 2017. Lack of the P2X7 receptor protects against AMD-like defects and microparticle accumulation in a chronic oxidative stress-induced mouse model of AMD. Biochemical and Biophysical Research Communications 482: 81\u201386. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.140.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2513_CR54","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31186","volume":"6","author":"Akira Karasawa","year":"2017","unstructured":"Karasawa, Akira, Kevin Michalski, Polina Mikhelzon, and Toshimitsu Kawate. 2017. The P2X7 receptor forms a dye-permeable pore independent of its intracellular domain but dependent on membrane lipid composition. eLife 6: e31186. https:\/\/doi.org\/10.7554\/eLife.31186.","journal-title":"eLife"},{"key":"2513_CR55","doi-asserted-by":"publisher","first-page":"105454","DOI":"10.1016\/j.ejps.2020.105454","volume":"152","author":"Eldio G Dos Santos","year":"2020","unstructured":"Dos Santos, Eldio G., X. Robson, Carlos R. Faria, Rodrigues, and Murilo L. Bello. 2020. Molecular dynamic simulations of full-length human purinergic receptor subtype P2X7 bonded to potent inhibitors. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 152:105454. https:\/\/doi.org\/10.1016\/j.ejps.2020.105454","journal-title":"European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences"},{"key":"2513_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1094607","volume":"13","author":"Gaia Pasqualetto","year":"2023","unstructured":"Pasqualetto, Gaia, Marika Zuanon, Andrea Brancale, and Mark T.. Young. 2023. Identification of a novel P2X7 antagonist using structure-based virtual screening. Frontiers in Pharmacology 13: 1094607. https:\/\/doi.org\/10.3389\/fphar.2022.1094607.","journal-title":"Frontiers in Pharmacology"},{"key":"2513_CR57","doi-asserted-by":"publisher","first-page":"114110","DOI":"10.1016\/j.bcp.2020.114110","volume":"178","author":"Chiara Bianca Platania","year":"2020","unstructured":"Platania, Chiara Bianca, Simona Maria, Carlo Ronchetti, Graziella Riccardi, Maria Cristina Migliorati, Luisa Di Marchetti, Francesca Paola, Filippo Lazzara, Salvatore Drago, Salomone, and Claudio Bucolo. 2020. Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR). Biochemical Pharmacology 178:114110. https:\/\/doi.org\/10.1016\/j.bcp.2020.114110","journal-title":"Biochemical Pharmacology"},{"key":"2513_CR58","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1007\/s00417-024-06507-9","volume":"262","author":"Kwang Woo","year":"2024","unstructured":"Woo, Kwang, M. Min, J. Abdallah Mahrous, Donald, Szilard D\u2019Amico, and Kiss, Kyle D. Kovacs. 2024. Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors. Graefe\u2019s Archive for Clinical and Experimental Ophthalmology\u2009=\u2009Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie 262:3493\u20133499. https:\/\/doi.org\/10.1007\/s00417-024-06507-9","journal-title":"Graefe\u2019s Archive for Clinical and Experimental Ophthalmology\u2009=\u2009Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie"},{"key":"2513_CR59","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1111\/bph.70007","volume":"182","author":"Chiara Bianca Platania","year":"2025","unstructured":"Platania, Chiara Bianca, Francesca Maria, Kenneth Lazzara, Naomi Mitton, Wendelin Haque, Federica Dailey, Erika Conti, and Giuffrida et al. 2025. Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy. British Journal of Pharmacology 182:2603\u20132620. https:\/\/doi.org\/10.1111\/bph.70007","journal-title":"British Journal of Pharmacology"},{"key":"2513_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fphar.2018.00039","volume":"9","author":"Anna L Di Virgilio, Francesco","year":"2018","unstructured":"Di Virgilio, Francesco, Anna L., Valentina Giuliani, Simonetta Vultaggio-Poma, Falzoni, and Alba C. Sarti. 2018. Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation. Frontiers in Pharmacology 9:39. https:\/\/doi.org\/10.3389\/fphar.2018.00039","journal-title":"Frontiers in Pharmacology"},{"key":"2513_CR61","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/jcdd12110438","volume":"12","author":"Bin Dayel","year":"2025","unstructured":"Dayel, Bin, F. Anfal, M. Reem, S. Alhejji, Asma, Alonazi, and Nouf M. Alrasheed. 2025. Role of P2X7 Receptor on Hypoxia-Induced Vascular Endothelial Growth Factor Gene Expression in H9c2 Rat Cardiomyocytes. Journal of Cardiovascular Development and Disease 12:438. https:\/\/doi.org\/10.3390\/jcdd12110438","journal-title":"Journal of Cardiovascular Development and Disease"},{"key":"2513_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125111","volume":"10","author":"Ramasri Sathanoori","year":"2015","unstructured":"Sathanoori, Ramasri, Karl Sw\u00e4rd, Bj\u00f6rn. Olde, and David Erlinge. 2015. The ATP receptors P2X7 and P2X4 modulate high glucose and palmitate-induced inflammatory responses in endothelial cells. PLoS One 10: e0125111. https:\/\/doi.org\/10.1371\/journal.pone.0125111.","journal-title":"PLoS One"},{"key":"2513_CR63","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/biomedicines13071743","volume":"13","author":"Xabier Miguel-L\u00f3pez","year":"2025","unstructured":"Miguel-L\u00f3pez, Xabier, Laura Prieto-L\u00f3pez, Elena Vecino, and Xandra Pereiro. 2025. Effect of Hypoxia on Adult M\u00fcller Glia Cultures. Biomedicines 13:1743. https:\/\/doi.org\/10.3390\/biomedicines13071743","journal-title":"Biomedicines"},{"key":"2513_CR64","doi-asserted-by":"publisher","first-page":"178602","DOI":"10.1016\/j.ejphar.2026.178602","volume":"1016","author":"Elsayed A Elmorsy","year":"2026","unstructured":"Elmorsy, Elsayed A., Manal Mohamed Hatem, Hamad Alsaykhan, Abdulaziz A. Alsalloom, M. Mostafa, Mohammed Khodeir, Rabab S. Alorini, and Hamad et al. 2026. Reprogramming lysosomal-purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin-P2X7 blockade in diabetic rats. European Journal of Pharmacology 1016:178602. https:\/\/doi.org\/10.1016\/j.ejphar.2026.178602","journal-title":"European Journal of Pharmacology"},{"key":"2513_CR65","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bcp.2016.07.020","volume":"116","author":"Emily A Caseley","year":"2016","unstructured":"Caseley, Emily A., P. Stephen, Colin W. Muench, and Fishwick, Lin-Hua Jiang. 2016. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists. Biochemical Pharmacology 116:130\u2013139. https:\/\/doi.org\/10.1016\/j.bcp.2016.07.020","journal-title":"Biochemical Pharmacology"},{"key":"2513_CR66","doi-asserted-by":"publisher","first-page":"8283","DOI":"10.1038\/s41467-025-62643-8","volume":"16","author":"Adam C Oken","year":"2025","unstructured":"Oken, Adam C., L. Andreea, Eva Turcu, Kyriakos Tzortzini, Jessica Georgiou, Franka G. Nagel, Marta Westermann, and Barniol-Xicota et al. 2025. A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptor. Nature Communications 16:8283. https:\/\/doi.org\/10.1038\/s41467-025-62643-8","journal-title":"Nature Communications"},{"key":"2513_CR67","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11302-013-9392-1","volume":"10","author":"Wolfgang Fischer","year":"2014","unstructured":"Fischer, Wolfgang, Nicole Urban, Kerstin Immig, Heike Franke, and Michael Schaefer. 2014. Natural compounds with P2X7 receptor-modulating properties. Purinergic Signalling 10: 313\u2013326. https:\/\/doi.org\/10.1007\/s11302-013-9392-1.","journal-title":"Purinergic Signalling"},{"key":"2513_CR68","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","volume":"41","author":"Asis Palazon","year":"2014","unstructured":"Palazon, Asis, Ananda W.. Goldrath, Victor Nizet, and Randall S.. Johnson. 2014. HIF transcription factors, inflammation, and immunity. Immunity 41: 518\u2013528. https:\/\/doi.org\/10.1016\/j.immuni.2014.09.008.","journal-title":"Immunity"},{"key":"2513_CR69","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s10753-021-01555-3","volume":"45","author":"Manhui Zhu","year":"2022","unstructured":"Zhu, Manhui, Ying Wang, Linling Zhu, Shu Du, Zhenzhen Wang, Yuting Zhang, Yang Guo, Yuanyuan Tu, and E. Song. 2022. Crosstalk between RPE cells and choroidal endothelial cells via the ANXA1\/FPR2\/SHP2\/NLRP3 inflammasome\/pyroptosis axis promotes choroidal neovascularization. Inflammation 45: 414\u2013427. https:\/\/doi.org\/10.1007\/s10753-021-01555-3.","journal-title":"Inflammation"},{"key":"2513_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094404","volume":"22","author":"Manuela Santonocito","year":"2021","unstructured":"Santonocito, Manuela, Cristina Zappulla, Santa Viola, Luca Rosario La Rosa, Elena Solfato, Ilenia Abbate, Valeria Tarallo, et al. 2021. Assessment of a new nanostructured microemulsion system for ocular delivery of Sorafenib to posterior segment of the eye. International Journal of Molecular Sciences 22: 4404. https:\/\/doi.org\/10.3390\/ijms22094404.","journal-title":"International Journal of Molecular Sciences"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02513-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:45:21Z","timestamp":1781649921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02513-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2513"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02513-7","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}